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Table	6.1.	A	summary	of	research	studies	which	have	investigated	reproducibility	of	diffusion	parameters.	In	this	table	‘Consistent	Acquisition’	means	there	were	no	differences	in	b	values,	field	strength	or	other	acquisition	methods	between	scans.			Study	Author	 Model	/Parameter	 Organ	 Methodology	 Main	Findings	Braithwaite	et	al.	20097	 ADC	 Healthy	abdominal	tissue:	Liver,	Spleen	Pancreas	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	Thoeny	et	al.	20058	 ADC	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	Cutajar	et	al.	20119	 ADC	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	and	low	variability	(<15%)	Jakab	et	al.	201710	 IVIM	 Healthy	Foetal	MRI	(Kidneys,	Liver,	Lungs)	 Consistent	Acquisition	 D*	and	f	had	greater	variability	(14	–	25%),	D	was	more	reproducible	(12	–	14%)	







DDC,	α,	Dk	<	10%).	D*,	f	and	K	had	the	highest	variability	(>30%)	Pentang	et	al.	201415	 Kurtosis	(Dk)	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 Dk	no	significant	differences,	however	this	was	based	on	one	volunteer	Kwee	et	al.	200816	 ADC	 Healthy	Liver	Tissue	 Breathing	Technique	Alteration	
Breath-hold	and	free	breathing	methods	provided	consistent	ADC	values.	Respiratory	triggering	gave	very	variable	ADC	values	Choi	et	al.	201317	 ADC	 Focal	Liver	Lesions	 Breathing	Technique	Alteration	 Breath-hold	and	free	breathing	methods	provided	consistent	ADC	values	Ye	et	al.	201418	 ADC	 Heathy	Pancreatic	Tissue	 Field	Strength	Alteration	 ADC	values	were	higher	when	acquired	on	1.5T	scanners	compared	to	3T	Barral	et	al.	201319	 ADC	 Heathy	Pancreatic	Tissue	 Field	Strength	Alteration	 No	significant	differences	in	ADC	between	1.5T	and	3T	

































































































Table	6.3.	Descriptive	statistics	for	each	field	strength	(1.5T	or	3T)	for	eight	diffusion	parameters.	Data	is	averaged	across	5	healthy	adult	kidneys	Field	Strength	 	 ADC	(x	10-3	mm2/s)	 D	(x	10-3	mm2/s)	 D*	(mm2/s)	 f	 Dk	(x	10-3	mm2/s)	 K	 DDC	(mm2/s)	 α	1.5T	 Mean	(Std)	 1.81	(6.31	x	10-5)	 1.62	(5.35	x	10-5)	 0.11	(0.09)	 0.27	(0.02)	 3.39	(1.71	x	10-4)	 0.76	(0.04)	 1.94	(0.34)	 0.74	(2.01	x	10-2)	3T	 Mean	(Std)	 1.86	(1.58	x	10-4)	 1.63	(3.59	x	10-5)	 0.36	(0.10)	 0.33	(0.11)	 3.79	(1.66	x	10-3)	 0.61	(0.10)	 1.85	x	10+4	(3.2	x	10+5)	 0.79	(3.85	x	10-2)	1.5T	 Median	 1.81	 1.63	 11.65	x	10-3	 0.26	 3.16	 0.79	 2.37	x	10-3	 0.75	
3T	 Median	 1.84	 1.66	 8.72	x	10-3	 0.29	 3.20	 0.70	 2.46	x	10-3	 0.80	




















ADC	 D	 D*	 f	 Dk	 K	 DDC	 α	
01	 0.83	 4.44	 59.0	 5.28	 19.49	 31.62	 141.41	 12.10	06	 0.49	 1.58	 129.17	 3.10	 1.41	 4.83	 6.14	 1.44	07	 2.22	 0.88	 103.93	 0.66	 7.41	 8.92	 119.40	 4.15	09	 9.99	 3.12	 56.13	 44.58	 47.77	 25.69	 141.42	 3.82	10	 0.95	 0.46	 43.74	 12.40	 3.23	 9.63	 133.77	 3.33	
MEAN	CV	
(%)	










ADC	 D	 D*	 f	 Dk	 K	 DDC	 a	
01	 23.17	 29.12	 13.57	 30.88	 33.45	 127.29	 141.19	 19.70	06	 0.80	 0.04	 14.91	 0.41	 0.38	 1.61	 141.42	 0.79	07	 0.40	 1.67	 17.60	 2.60	 2.72	 5.07	 141.42	 1.31	09	 6.39	 5.55	 28.35	 37.87	 47.92	 24.31	 16.53	 1.95	10	 0.59	 3.21	 64.92	 12.00	 3.50	 0.83	 141.42	 1.29	
MEAN	CV	
(%)	











































Table	6.7.	Percent	of	voxels	within	the	kidney	ROIs	which	showed	DDC	values	above	diffusivity	of	free	water	at	body	temperature	and	maximum	DDC	values	within	the	ROIs			 1.5T	 3T	(8	b	values)	 3T	(7	b	values)	
Volunteer	ID	 %	High	Voxels	 Maximum	DDC	Value	(mm2/s)	 %	High	Voxels	
Maximum	DDC	Value	(mm2/s)	 %	High	Voxels	
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	 7	b	values	n	=	23	 8	b	values	n	=	27	 7	b	values	n	=	28	 8	b	values	n	=	34	Mono-exponential	 0%	 0%	 0%	 2.9%	IVIM	 21.7%	 0%	 28.6%	 23.5%	Stretched	exponential	 52.2%	 70.4%	 35.7%	 58.8%	Kurtosis	 26.1%	 29.6%	 35.7%	 14.7%	
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Table	8.1.		The	p-values,	adjusted	R2	and	correlation	coefficients	(β)	of	the	nine	multiple	regression	models	used	to	predict	Fractional	Enhancement,	based	on	a	combination	of	T1wnorm	and	one	of	the	diffusion	parameters.	ADC,	D,	D*,	f	x	D*,	DDC,	Dk	were	all	measured	in	standard	units	of	mm/s2.		f,	α,	K,	and	T1wnorm	are	unitless	Diffusion	Parameter	 β0	(Intercept)	 β1	(Diffusion)	 β2	(T1wnorm)	 Model	p	Value	 Model	Adjusted	R2	ADC		(mono-exponential)	 1.85	 -408.4	 -0.4	 5.7	x	10-5	 0.40	
D	(IVIM)	 1.83	 -419.64	 -0.4	 4.2	x	10-5	 0.42	
D*	(IVIM)	 1.18	 -1.09	 -0.3	 0.017	 0.17	
f	(IVIM)	 1.01	 1.07	 -0.34	 0.025	 0.15	
f	x	D*	(IVIM)	 1.2	 -5.53	 -0.33	 0.023	 0.15	
DDC	
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	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	ADC	(mono-exponential)	 1.24	x	10
-3	(2.06	x	10-4)	 0.92	x	10-3	 1.02	x	10-3	(2.11	x	10-4)	 0.80	x	10-3	 1.70	x	10-3	(2.47	x	10-4)	 1.50	x	10-3	 1.39	x	10-3	(2.83	x	10-4)	 1.10	x	10-3	 1.41	x	10-3	(3.5	x	10-4)	 1.10	x	10-3	
D	(IVIM)	 1.14	x	10-3	(2.12	x	10-4)	 0.83	x	10-3	 0.92	x	10-3	(1.93	x	10-4)	 0.73	x	10-3	 1.60	x	10-3	(2.32	x	10-4)	 1.39	x	10-3	 1.30	x	10-3	(2.74	x	10-4)	 1.01	x	10-3	 1.33	x	10-3	(3.43	x	10-4)	 1.02	x	10-3	
D*	(IVIM)	 90.3	x	10-3	(11.0	x	10-2)	 4.09	x	10-3	 69.2	x	10-3	(7.72	x	10-2)	 6.71	x	10-3	 66.6	x	10-3	(14.5	x	10-2)	 3.34	x	10-3	 43.3	x	10-3	(6.52	x	10-2)	 3.97	x	10-3	 88.2	x	10-3	(5.16	x	10-2)	 2.75	x	10-3	
f	(IVIM)	 0.18	(0.04)	 0.11	 0.15	(0.03)	 0.09	 0.18	(0.06)	 0.10	 0.15	(0.04)	 0.09	 0.71	(0.02)	 0.75	




DDC	(stretched	exponential)	 0.56	(1.47)	 0.93	x	10-3	 8.79	(23.2)	 0.79	x	10-3	 1.27	x	10
-2	(382.72)	 1.62	x	10-3	 0.14	(0.49)	 1.14	x	10-3	 5.18	x	10+6	(1.37	x	10+7)	 1.14	x	10-3	α	(stretched	exponential)	 0.81	(3.71	x	10-2)	 0.74	 0.76	(4.08	x	10-2)	 0.70	 0.87	(4.28	x	10-2)	 0.83	 0.85	(3.86	x	10-2)	 0.79	 0.87	(5.41	x	10-2)	 0.81	
Dk	(kurtosis)	 1.85	x	10-3	(2.99	x	10-4)	 1.32	x	10-3	 1.89	x	10-3	(4.47	x	10-4)	 1.21	x	10-3	 2.33	x	10-3	(4.28	x	10-4)	 1.87	x	10-3	 1.99	x	10-3	(3.53	x	10-4)	 1.45	x	10-3	 2.01	x	10-3	(4.53	x	10-4)	 1.37	x	10-3	













	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	ADC	(mono-exponential)	 1.34	x	10
-3	(4.09	x	10-4)	 1.01	x	10-3	 1.02	x	10-3	(2.12	x	10-4)	 0.80	x	10-3	 1.74	x	10-3	(2.4	x	10-4)	 1.50	x	10-3	 1.42	x	10-3	(3.11	x	10-4)	 1.11	x	10-3	 1.50	x	10-3	(4.18	x	10-4)	 1.15	x	10-3	
D	(IVIM)	 1.24	x	10-3	(4.32	x	10-4)	 0.91	x	10-3	 0.92	x	10-3	(1.93	x	10-4)	 0.73	x	10-3	 1.65	x	10-3	(2.27	x	10-4)	 1.40	x	10-3	 1.33	x	10-3	(2.98	x	10-4)	 1.03	x	10-3	 1.42	x	10-3	(4.21	x	10-4)	 1.08	x	10-3	
D*	(IVIM)	 90.8	x	10-3	(10.9	x	10-2)	 3.74	x	10-3	 69.2	x	10-3	(7.72	x	10-2)	 6.71	x	10-3	 101	x	10-3	(14.3	x	10-2)	 3.26	x	10-3	 58.3	x	10-3	(6.69	x	10-2)	 3.89	x	10-3	 88.9	x	10-3	(4.90	x	10-2)	 2.56	x	10-3	
f	(IVIM)	 0.18	(0.04)	 0.10	 0.15	(0.03)	 0.10	 0.18	(0.06)	 0.10	 0.16	(0.04)	 0.09	 0.18	(0.03)	 0.07	




	(1.77)	 1.06	x	10-3	 8.79	(23.2)	 0.79	x	10-3	 1.15	x	10+2	(3.79	x	10+2)	 1.63	x	10-3	 12.9	(0.49)	 1.16	x	10-3	 4.68	x	10+6	(1.24	x	10+7)	 1.21	x	10-3	α	(stretched	exponential)	 0.83	(4.88	x	10-2)	 0.75	 0.76	(1.08	x	10-2)	 0.70	 0.88	(4.37	x	10-2)	 0.83	 0.85	(3.94	x	10-2)	 0.79	 0.87	(5.62	x	10-2)	 0.82	
Dk	(kurtosis)	 1.91	x	10-3	(3.79	x	10-4)	 1.45	x	10-3	 1.89	x	10-3	(4.47	x	10-4)	 1.21	x	10-3	 2.36	x	10-3	(4.15	x	10-4)	 1.89	x	10-3	 2.03	x	10-3	(3.76	x	10-4)	 1.48	x	10-3	 2.08	x	10-3	(4.82	x	10-4)	 1.44	x	10-3	
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Conclusions		- Differences	in	reproducibility	were	found	between	the	parameters.	- The	greatest	variability	was	found	in	D*	and	K	as	expected,	however	f	was	found	to	be	reproducible.	DDC,	was	also	found	to	be	highly	variable.		- ADC,	D,	Dk,	and	α	were	all	found	to	have	low	variability	
Main	Finding:	Most	parameters	(ADC,	D,	Dk,	and	α)	are	reproducible	across	field	strengths	and	when	different	b	values	are	acquired.	More	caution	needs	to	be	taken	when	interpreting	D*,	K	and	DDC	as	these	parameters	have	high	levels	of	variability.			
10.1.2:	Summaries:	Chapter	7	Summary		 The	second	study	tested	the	how	well	each	of	the	four	diffusion	models	described	the	raw	diffusion	data	in	Wilms’	tumours,	and	the	contralateral	unaffected	normal	kidney.	Goodness	of	fit	was	based	on	the	Akaike	information	criterion.		

















Aims	and	Hypotheses:	- There	will	be	significant	differences	between	the	subtypes	based	on	diffusion	values.		- The	non-Gaussian	models	will	provide	more	subtype	separations	compared	to	the	mono-exponential	model	- The	blastemal	and	epithelial	subtypes	will	have	lower	ADC	values	compared	to	the	other	subtypes.	- The	stromal	subtype	will	have	the	highest	ADC	values	compared	to	the	other	subtypes.		- Limiting	the	analysis	to	just	the	viable	tumour	tissue	will	provide	more	significant	differences	between	the	subtypes	compared	to	using	the	whole	tumour	values.	
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